Literature DB >> 21930940

Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses.

Naokazu Chiba1, Valentine Comaills, Bunsyo Shiotani, Fumiyuki Takahashi, Toshiyuki Shimada, Ken Tajima, Daniel Winokur, Tetsu Hayashida, Henning Willers, Elena Brachtel, Maria D M Vivanco, Daniel A Haber, Lee Zou, Shyamala Maheswaran.   

Abstract

Homeobox 9 (HOXB9), a nontransforming transcription factor overexpressed in breast cancer, alters tumor cell fate and promotes tumor progression and metastasis. Here we show that HOXB9 confers resistance to ionizing radiation by promoting DNA damage response. In nonirradiated cells, HOXB9 induces spontaneous DNA damage, phosphorylated histone 2AX and p53 binding protein 1 foci, and increases baseline ataxia telangiectasia mutated (ATM) phosphorylation. Upon ionizing radiation, ATM is hyperactivated in HOXB9-expressing cells during the early stages of the double-stranded DNA break (DSB) response, accelerating accumulation of phosphorylated histone 2AX, mediator of DNA-damage checkpoint 1, and p53 binding protein 1, at DSBs and enhances DSB repair. The effect of HOXB9 on the response to ionizing radiation requires the baseline ATM activity before irradiation and epithelial-to-mesenchymal transition induced by TGF-β, a HOXB9 transcriptional target. Our results reveal the impact of a HOXB9-TGF-β-ATM axis on checkpoint activation and DNA repair, suggesting that TGF-β may be a key factor that links tumor microenvironment, tumor cell fate, DNA damage response, and radioresistance in a subset of HOXB9-overexpressing breast tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930940      PMCID: PMC3286905          DOI: 10.1073/pnas.1018867108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

Review 2.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 4.  Sensing, signaling, and responding to DNA damage: organization of the checkpoint pathways in mammalian cells.

Authors:  Lei Li; Lee Zou
Journal:  J Cell Biochem       Date:  2005-02-01       Impact factor: 4.429

5.  Cell biology. Guiding ATM to broken DNA.

Authors:  Robert T Abraham; Randal S Tibbetts
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

Review 6.  Radiation and the microenvironment - tumorigenesis and therapy.

Authors:  Mary Helen Barcellos-Hoff; Catherine Park; Eric G Wright
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

7.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Sonia Franco; Monica Gostissa; Melissa A Rivera; Arkady Celeste; John P Manis; Jan van Deursen; André Nussenzweig; Tanya T Paull; Frederick W Alt; Junjie Chen
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

8.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.

Authors:  Derek C Radisky; Dinah D Levy; Laurie E Littlepage; Hong Liu; Celeste M Nelson; Jimmie E Fata; Devin Leake; Elizabeth L Godden; Donna G Albertson; M Angela Nieto; Zena Werb; Mina J Bissell
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

9.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

10.  Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

Authors:  Dong Young Rhyu; Yanqiang Yang; Hunjoo Ha; Geun Taek Lee; Jae Sook Song; Soo-taek Uh; Hi Bahl Lee
Journal:  J Am Soc Nephrol       Date:  2005-01-26       Impact factor: 10.121

View more
  37 in total

1.  Progress in breast cancer research.

Authors:  Kornelia Polyak; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

2.  Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.

Authors:  Kai Huang; Rongfa Yuan; Kai Wang; Junwen Hu; Zixi Huang; Chen Yan; Wei Shen; Jianghua Shao
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 3.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

Review 4.  Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.

Authors:  Elisa Pezzolo; Yasmina Modena; Barbara Corso; Pietro Giusti; Milena Gusella
Journal:  Eur J Clin Pharmacol       Date:  2015-03-06       Impact factor: 2.953

Review 5.  The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.

Authors:  Danupon Nantajit; Dong Lin; Jian Jian Li
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-01       Impact factor: 4.553

6.  Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.

Authors:  Paromita Deb; Arunoday Bhan; Imran Hussain; Khairul I Ansari; Samara A Bobzean; Tej K Pandita; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Gene       Date:  2016-05-13       Impact factor: 3.688

7.  SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.

Authors:  Sungguan Hong; Hyangsoon Noh; Yong Teng; Jing Shao; Hina Rehmani; Han-Fei Ding; Zheng Dong; Shi-Bing Su; Huidong Shi; Jaejik Kim; Shuang Huang
Journal:  Neoplasia       Date:  2014-04-18       Impact factor: 5.715

8.  Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue.

Authors:  Bishakha Shrestha; Khairul I Ansari; Arunoday Bhan; Sahba Kasiri; Imran Hussain; Subhrangsu S Mandal
Journal:  FEBS J       Date:  2012-08-31       Impact factor: 5.542

9.  Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.

Authors:  Huafang Su; Xiance Jin; Lanxiao Shen; Ya Fang; Zhenghua Fei; Xuebang Zhang; Congying Xie; Xiaolei Chen
Journal:  Tumour Biol       Date:  2015-11-11

10.  A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.

Authors:  Jenny Fung Ling Chau; Deyong Jia; Zhongfeng Wang; Zhi Liu; Yuanyu Hu; Xin Zhang; Hao Jia; Keng Po Lai; Wai Fook Leong; Bi Jin Au; Yuji Mishina; Ye-Guang Chen; Christine Biondi; Elizabeth Robertson; Dong Xie; Huijuan Liu; Lin He; Xueying Wang; Qiang Yu; Baojie Li
Journal:  Nat Commun       Date:  2012-05-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.